Actithera
Actithera is a biotechnology company focused on developing innovative therapies using its proprietary three-pillar discovery platform, which is designed to enable prolonged radioligand tumor retention. The company is advancing clinical development of its fibroblast activation protein (FAP)-targeting candidate and aims to expand its therapeutic pipeline.
Leadership & Board
- Current Number of Employees
- 38
- Current LinkedIn Followers
- 3,806
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $76M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $76M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
Actithera had 38 employees as of October 12, 2026. The number of employees increased by 1 (2.70%) week-over-week.
38Latest Employee Count
1(2.70%)Week-Over-Week Change
Social Trend
Actithera had 3,806 followers as of October 12, 2026. The number of followers increased by 16 (0.42%) week-over-week.
3,806Latest Followers Count
16(0.42%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 09, 2025 | Series A | $75.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| M Ventures | Series A |
| Sofinnova Partners | Series A |
| Surveyor Capital | Series A |
| Bioqube Ventures | Series A |
| Hadean Ventures | Series A |
| 4BIO Capital | Series A |
Similar Companies
A snapshot of private companies similar to Actithera, helping you discover and navigate related company profiles.
Related News and Analysis
